Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients.

Friederike HeldSudhakar Reddy KalluriAchim BertheleAna-Katharina KleinMarkus Reindl Bernhard Hemmer

Published in: Multiple sclerosis journal - experimental, translational and clinical (2021)

The present study demonstrates the occurrence of MOG-Ab in a wide range of neurological diseases. Only high MOG-Ab ratios were associated with a defined clinical phenotype, but low MOG-Ab ratios were not. The diagnostic value of low MOG-Ab is thus highly limited.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
risk assessment
peritoneal dialysis
multiple sclerosis
brain injury
patient reported
subarachnoid hemorrhage
neural stem cells